N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 23.13 CNY -2.16% Market Closed
Market Cap: 9.3B CNY
Have any thoughts about
Nanjing Vazyme Biotech Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Nanjing Vazyme Biotech Co Ltd

Current Assets 3.5B
Cash & Short-Term Investments 2.6B
Receivables 499m
Other Current Assets 407.7m
Non-Current Assets 1.5B
Long-Term Investments 52.3m
PP&E 777.3m
Intangibles 227.6m
Other Non-Current Assets 435.8m
Current Liabilities 763.4m
Accounts Payable 89.7m
Accrued Liabilities 82.3m
Short-Term Debt 492.2m
Other Current Liabilities 99.2m
Non-Current Liabilities 239m
Long-Term Debt 172.4m
Other Non-Current Liabilities 66.7m

Balance Sheet
Nanjing Vazyme Biotech Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
83
94
222
1 478
1 345
848
Cash
0
0
0
0
1 345
848
Cash Equivalents
83
94
222
1 478
0
0
Short-Term Investments
9
0
796
1 976
1 919
2 633
Total Receivables
53
81
234
334
855
366
Accounts Receivables
40
71
226
322
838
352
Other Receivables
13
10
8
12
17
14
Inventory
28
53
132
242
364
346
Other Current Assets
2
4
12
21
82
37
Total Current Assets
176
233
1 396
4 051
4 565
4 230
PP&E Net
28
35
134
343
785
836
PP&E Gross
28
35
134
343
785
836
Accumulated Depreciation
10
16
27
74
387
485
Intangible Assets
1
2
7
17
50
101
Goodwill
0
0
0
0
130
130
Note Receivable
0
0
0
0
0
0
Long-Term Investments
0
0
0
18
22
47
Other Long-Term Assets
46
54
75
178
452
401
Other Assets
0
0
0
0
130
130
Total Assets
251
N/A
324
+29%
1 612
+397%
4 607
+186%
6 005
+30%
5 746
-4%
Liabilities
Accounts Payable
13
17
59
119
293
147
Accrued Liabilities
14
28
55
106
272
116
Short-Term Debt
31
36
1
0
298
1 132
Current Portion of Long-Term Debt
0
0
0
31
58
46
Other Current Liabilities
22
28
124
132
233
78
Total Current Liabilities
80
108
239
387
1 154
1 520
Long-Term Debt
0
0
0
60
128
107
Deferred Income Tax
0
0
0
1
11
2
Minority Interest
0
0
0
0
3
0
Other Liabilities
5
16
40
32
100
89
Total Liabilities
85
N/A
124
+47%
279
+125%
480
+72%
1 396
+191%
1 717
+23%
Equity
Common Stock
15
15
360
400
400
400
Retained Earnings
34
8
627
1 305
1 780
1 209
Additional Paid In Capital
185
193
345
2 422
2 429
2 442
Treasury Stock
0
0
0
0
0
20
Other Equity
0
0
0
0
0
2
Total Equity
166
N/A
200
+20%
1 332
+566%
4 127
+210%
4 609
+12%
4 029
-13%
Total Liabilities & Equity
251
N/A
324
+29%
1 612
+397%
4 607
+186%
6 005
+30%
5 746
-4%
Shares Outstanding
Common Shares Outstanding
400
400
400
400
400
399

See Also

Discover More